KMT2A and leukemia: While irinotecan monotherapy was able to completely block human MLL-rearranged ALL expansion in mice when treatment was initiated shortly after xenotransplantation, this may not represent a clinically relevant model, as patients present with full-blown leukemia at diagnosis.